Metallopanstimulin as a marker for head and neck cancer

Brendan C. Stack, Christopher S. Hollenbeak, Christopher M. Lee, Frank R. Dunphy, Val J. Lowe, Paul D. Hamilton

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Background: Metallopanstimulin (MPS-1) is a ribosomal protein that is found in elevated amounts in the sera of patients with head and neck squamous cell carcinoma (HNSCC). We used a test, denoted MPS-H, which detects MPS-1 and MPS-1-like proteins, to determine the relationship between MPS-H serum levels and clinical status of patients with, or at risk for, HNSCC. Patients and methods: A total of 125 patients were prospectively enrolled from a university head and neck oncology clinic. Participants included only newly diagnosed HNSCC patients. Two control groups, including 25 non-smokers and 64 smokers, were studied for comparison. A total of 821 serum samples collected over a twenty-four month period were analyzed by the MPS-H radioimmunoassay. Results: HNSCC, non-smokers, and smokers had average MPS-H values of 41.5 ng/mL, 10.2 ng/mL, and 12.8 ng/mL, respectively (p = 0.0001). Conclusion: We conclude that MPS-1 and MPS-1-like proteins are elevated in patients with HNSCC, and that MPS-H appears to be a promising marker of presence of disease and response to treatment in HNSCC patients.

Original languageEnglish (US)
Article number45
JournalWorld Journal of Surgical Oncology
StatePublished - Dec 14 2004

ASJC Scopus subject areas

  • Surgery
  • Oncology


Dive into the research topics of 'Metallopanstimulin as a marker for head and neck cancer'. Together they form a unique fingerprint.

Cite this